Predicting toxicity after RT for head and neck cancer: combining dosimetry with a biomarker

150%;font-family:"Calibri",sans-serif;mso-ascii-theme-font:minor-latin; mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;color:black; mso-color-alt:windowtext;mso-ansi-language:EN-GB;mso-bidi-font-weight:bold"…" />

We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.